Company intelligence / Profile preview

CellReady

Houston, Texas, United Statescellready.com ↗

Ownership: Private
Development stage: Commercial

Overview

CellReady is the world’s first and only G-Rex centric CDMO specializing in the development and manufacturing of cell and gene-modified cell therapies. It provides end-to-end services to support the commercialization of these therapies, with a focus on oncology. The company leverages its proprietary G-Rex technology platform to enable scalable, efficient, GMP-compliant production.

Therapeutic areas: Oncology
Modalities: Cell therapyGene-modified cell therapy
Industry: Contract Manufacturing Organization

Partnerships

Marker TherapeuticsScaleReady joint venture partners including Wilson Wolf Manufacturing and Bio-Techne

Beyond the preview

Go deeper on CellReady.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CellReady.

Explore the full profile